Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


MTI joins 3i in £6.5 million ApaTech investment:

This article was originally published in Clinica

Executive Summary

UK venture capital firm MTI has invested in bone material specialist ApaTech, and the London-based company's original backer, 3i, has also reinvested. The latest £6.5m ($11.5m) investment is aimed at helping the company market its products globally; 3i's initial £3m funding in July 2001 enabled it to CE mark its ApaPore synthetic bone graft material and launch it in the UK and New Zealand. ApaTech intends to launch a second product, Pore-Si (a silicate-substituted apatite that could find applications in spinal fusion), later in 2004. The company was spun out of Queen Mary University of London.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts